June 10, 2026 · Form 4 insider transaction
Jenkins John Kenneth sold 4,800 shares of Corbus Pharmaceuticals Holdings, Inc. at $7.91 per share, a transaction worth $38.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026.; The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.71 to $7.97. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.; This amount includes 3,800 unvested RSUs subject to the grant's vesting schedule as previously reported.